Outlook Therapeutics Inc (OTLK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | OTLK | AMGN | VRTX | REGN | GILD |
| Company | Outlook Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 7.19 | 326.27 | 482.39 | 1,195.72 | 76.09 |
| High | 7.89 | 331.29 | 486.77 | 1,202.24 | 77.12 |
| Low | 7.15 | 325.38 | 481.19 | 1,190.00 | 75.91 |
| Last | 7.53 | 328.80 | 481.24 | 1,199.12 | 76.72 |
| Change | +0.36 | +4.27 | +1.35 | +11.46 | +0.82 |
| % Change | +5.02% | +1.32% | +0.28% | +0.96% | +1.08% |
| Volume | 179,000 | 1,771,000 | 999,600 | 352,600 | 6,847,000 |
| 20-Day Average Volume | 163,185 | 2,023,340 | 1,232,055 | 490,735 | 5,648,000 |
| Previous Close | 7.17 | 324.53 | 479.89 | 1,187.66 | 75.90 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 7.42 | 326.68 | 481.19 | 1,130.58 | 75.18 |
| 20-Day Raw Stochastic | 38.89% | 64.75% | 44.11% | 97.30% | 71.26% |
| 20-Day Relative Strength | 49.28% | 53.91% | 51.57% | 72.12% | 61.45% |
| Weighted Alpha | -22.32 | +28.63 | +37.03 | +51.80 | +3.11 |
| Today's Opinion | 88% Sell | 88% Buy | 56% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 56% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 24% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.33% since 08/16/24 | +2.29% since 08/16/24 | +0.81% since 08/16/24 | +1.68% since 08/16/24 | +3.98% since 08/16/24 |
| Low | 7.05 on 08/20/24 | 321.41 on 08/19/24 | 476.00 on 08/19/24 | 1,178.18 on 08/19/24 | 73.27 on 08/19/24 |
| High | 7.89 on 08/23/24 | 331.29 on 08/23/24 | 491.88 on 08/21/24 | 1,203.49 on 08/21/24 | 77.12 on 08/23/24 |
| 1-Month | |||||
| %Chg | -11.62% since 07/23/24 | -1.33% since 07/23/24 | -1.85% since 07/23/24 | +13.60% since 07/23/24 | +7.80% since 07/23/24 |
| Low | 6.90 on 08/05/24 | 306.59 on 08/07/24 | 458.04 on 08/13/24 | 1,041.85 on 08/01/24 | 71.42 on 07/24/24 |
| High | 8.70 on 07/26/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,203.49 on 08/21/24 | 78.45 on 07/30/24 |
| 3-Month | |||||
| %Chg | unch since 05/23/24 | +7.28% since 05/23/24 | +6.75% since 05/23/24 | +22.29% since 05/23/24 | +15.94% since 05/23/24 |
| Low | 6.65 on 06/07/24 | 295.30 on 06/13/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 62.07 on 05/31/24 |
| High | 9.25 on 07/17/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,203.49 on 08/21/24 | 78.45 on 07/30/24 |
| 6-Month | |||||
| %Chg | -14.16% since 02/23/24 | +13.70% since 02/23/24 | +11.89% since 02/23/24 | +22.21% since 02/23/24 | +4.31% since 02/23/24 |
| Low | 5.04 on 03/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 62.07 on 05/31/24 |
| High | 12.85 on 04/01/24 | 346.85 on 07/25/24 | 510.64 on 08/01/24 | 1,203.49 on 08/21/24 | 78.45 on 07/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 176,247 | 176,379,824 | 124,185,432 | 132,126,224 | 95,581,848 |
| Shares Outstanding, K | 23,406 | 536,435 | 258,053 | 110,186 | 1,245,853 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 27,116,000,000 |
| Annual Net Income | -58,980,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 5,665,000,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 2,645,600,000 | 3,547,100,000 | 6,954,000,000 |
| Last Quarter Net Income | 44,410,000 | 746,000,000 | -3,593,600,000 | 1,432,300,000 | 1,614,000,000 |
| 60-Month Beta | 0.71 | 0.58 | 0.39 | 0.13 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.83 on 08/14/24 | 4.97 on 08/06/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/14/24 | 08/06/24 | 08/01/24 | 08/01/24 | 08/08/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | N/A | N/A | 0.770 on 06/14/24 |
| Next Ex-Dividends Date | N/A | 08/16/24 | N/A | N/A | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.45 | 0.00 | 30.91 | 16.15 |